EMS-Chemie Holding AG (0QM9)
London Exchange · UK · prices in GBP · close of 22 Oct 2026
Key indicators
| Last close | GBP 882.00 |
|---|---|
| 52-week range | 530.00 – 895.75 |
| Return, 1 month / 3 months | +5.8% / +13.1% |
| Return, 1 year / 3 years | +54.7% / +47.2% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 20.2% |
| Worst drawdown (1 year) | -8.4% |
| Average daily value traded | 4.03M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
EMS-Chemie Holding is a Swiss specialty chemicals company based in Herrliberg. It develops and produces high-performance polymers and engineering plastics, including polyamides and copolyamides, which are supplied to makers of automotive parts, electrical and electronic components, and consumer goods. The company also provides related services and technical support to industrial customers. Its products are used where strength, heat resistance and light weight matter, and it serves manufacturers and processors across Europe and other regions.
The shares are listed on the London Exchange in UK under the code 0QM9, and the price on this page is in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
EMS-Chemie Holding AG (0QM9) trades on the London Exchange in UK. It last closed at GBP 882.00 on 22 October 2026.
Its price-based Market X-Ray is 85 out of 100 (a strong price profile), ranking 5 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 54.7% and over the last three months it rose 13.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 24.6% | ||
| From 52-week high | -1.5% | ||
| Momentum | 86 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.1% | ||
| 6-month return | 32.1% | ||
| 12-month return, skipping the last month | 46.2% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -8.4% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.03M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +5.8% |
| 3 months | +13.1% |
| 6 months | +32.1% |
| 1 year | +54.7% |
| 3 years | +47.2% |
| 5 years | −4.7% |
Signals
| 50-day / 200-day average | 816.85 / 707.59 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 18.83 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Aug 2026 | GBX 0.1465 |
| 12 Aug 2025 | GBX 0.0330 |
| 13 Aug 2024 | GBX 0.1275 |
| 15 Aug 2023 | GBX 0.1575 |
| 16 Aug 2022 | GBX 0.1650 |
| 10 Aug 2021 | GBX 0.1300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.